NASDAQ: RCEL · Medical Devices
Over the past week, AVITA Medical (RCEL) drew about 108 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 35% bullish but is deeply split: News runs 60% bullish while X sits at just 9%. Wall Street is more constructive, with 2 of 3 analysts rating RCEL a buy.
There is little buzz around RCEL this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 67% buy share sits next to a crowd that ranges from X at 9% to News at 60%. No other tracker puts the two side by side.
Across 3 analysts the consensus is a Strong Buy: 2 buy calls against 0 sell, with an average 12-month price target of $9.05.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 2 sources disagree sharply, so the read is a Sell.
Analysts sit 32 points above the crowd average of 35%, the professionals are more constructive than retail. The split is inside the crowd: News reads 60% bullish while X sits at 9%, a 51-point spread that single-source trackers miss.
Over the 30-day window, AVITA Medical (RCEL) buzz held subdued around 35.4 while the price drifted up 53.9% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 621K shares. Updated Aug 15, 2026. Over the last 7 trading days, RCEL gained 65.3%. Buzz activity in the recent week averaged 37.8 and was variable, swinging between 26.7 and 54.8. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 6 of the 7 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for RCEL and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live RCEL sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (2 / 1 / 0) |
| Crowd bullish (7d) | 35% |
| Avg price target | $9.05 |
| Most bullish source | News, 60% |
| Most bearish source | X, 9% |
| Sentiment spread | 51 pts |
| Mentions (7d) | 108 |
| Market cap | $242.8M |
| P/E · Forward P/E | n/a · 10.3 |
| EPS · Beta | -$1.41 · 1.9 |
| Revenue (TTM) | $75.6M · -57% margin |
| Industry | Medical Devices |
Based on aggregated sentiment from X and News sources, AVITA Medical (RCEL) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 35% bullish across 2 active sources. Those sources contribute 108 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
The crowd reads bearish on AVITA Medical (RCEL), averaging 35% bullish across 2 tracked sources over the last 7 days. The two ends of the range are News at 60% bullish and X at 9%, a 51-point spread. On the professional side, 2 of 3 analysts rate RCEL a buy.
Of the 3 analysts covering AVITA Medical (RCEL), 2 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $9.05. That puts the street ahead of the crowd, which averages 35% bullish.
AVITA Medical (RCEL)'s cross-source average is bearish at 35% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish. News reads 60% bullish and x coverage is the most negative at 9% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for AVITA Medical (RCEL) at 35% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish. The most bearish reading is x at 9% bullish. 3-day activity momentum is rising across X. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 103 mentions (95% of total volume). News contributes 5 mentions. The cross-source average is bearish at 35% bullish, while x is the only source with rising 3-day activity. Source readings are split: 1 source leans bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. RCEL's sell signal at 93/100 conviction reflects a bearish cross-source average at 35% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The RCEL sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key